Fny Investment Advisers, LLC Uni Qure N.V. Transaction History

Fny Investment Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 09, 2020	SELL	$35.98 - $47.66 $7,195 - $9,532	-200 Closed	0 $0
Q1 2020 Apr 09, 2020	SELL	$40.01 - $73.97 $24,006 - $44,382	-600 Reduced 75.0%	200 $9,000
Q4 2019 Jan 10, 2020	SELL	$37.13 - $74.62 $235,626 - $473,538	-6,346 Reduced 88.8%	800 $57,000
Q3 2019 Oct 25, 2019	BUY	$39.36 - $76.8 $281,266 - $548,812	7,146 New	7,146 $281,000
Q4 2018 Jan 22, 2019	SELL	$22.8 - $33.93 $22,800 - $33,930	-1,000 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$29.75 - $43.08 $5,950 - $8,616	200 Added 25.0%	1,000 $36,000
Q2 2018 Jul 18, 2018	BUY	$21.96 - $39.94 $17,568 - $31,952	800 New	800 $30,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.